HIND
NASDAQ · Pharmaceuticals
Vyome Holdings Inc
$2.16
+0.02 (+0.93%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+785.2% upside
Low Target
$13.94
Average Target
$19.12
High Target
$23.15
Current Price
$2.16
Current
$2.16
$2.16
Target
$19.12
$19.12
$13.94
$19.12 avg
$23.15
Scenario Analysis
Bear Case
$13.94
545.4%
Low target
Base Case
$19.12
+785.2%
Avg target
Bull Case
$23.15
+971.8%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$18.60
-88.4% from high
52-Week Low
$1.75
+23.4% from low
Target vs 52W High
$19.12
+2.8% vs high
Next Earnings Report
Aug 12, 2026
3d
until earnings
EPS Est: $-0.19
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals